查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1325095

基于人体模型的模拟的全球市场

Mannequin-Based Simulation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 268 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球人体模型模拟市场规模将达到 56 亿美元

在COVID-19之后的商业环境发生变化的情况下，基于人体模型的模拟的全球市场规模预计2022年为17亿美元，预计到2030年将达到56亿美元，年复合成长率预计为15.8% 。本报告分析的细分市场之一——模拟病人，预计年复合成长率15.3%，到分析期结束时将达到 38 亿美元。鑑于疫情后的持续復苏，其他产品类型细分市场的增长在未来八年修正为 16.8% 的年复合成长率。

美国市场预计为7.588亿美元，中国预计复合年增长率为19.3%

到 2022 年，美国基于人体模型的模拟市场预计将达到 7.588 亿美元。中国作为世界第二大经济体，预计到2030年市场规模将达到3.474亿美元，2022年至2030年復合年增长率为19.3%。其他值得注意的地域市场包括日本和加拿大，预计 2022 年至 2030 年将分别增长 12.3% 和 14.6%。在欧洲，德国的年复合成长率预计约为 14.5%。

受访企业示例

  • Moog, Inc.
  • Laerdal Medical AS
  • Ambu A/S
  • 3B Scientific GmbH
  • Cardionics
  • DentalEZ, Inc.
  • Gaumard Scientific Co., Inc.
  • IngMar Medical
  • Kyoto Kagaku Co., Ltd.
  • Mentice AB
  • CAE Healthcare
  • Adam Rouilly Ltd.
  • Global Technologies
  • KOKEN CO., LTD.
  • LifeCast Body Simulation Ltd.

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 大公司
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 我们
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第4章竞争

简介目录
Product Code: MCP-3220

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Mannequin-Based Simulation Market to Reach $5.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Mannequin-Based Simulation estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$5.6 Billion by 2030, growing at aCAGR of 15.8% over the period 2022-2030. Patient Simulators, one of the segments analyzed in the report, is projected to record 15.3% CAGR and reach US$3.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Other Product Types segment is readjusted to a revised 16.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $758.8 Million, While China is Forecast to Grow at 19.3% CAGR

The Mannequin-Based Simulation market in the U.S. is estimated at US$758.8 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$347.4 Million by the year 2030 trailing a CAGR of 19.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.3% and 14.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.5% CAGR.

Select Competitors (Total 55 Featured) -

  • Moog, Inc.
  • Laerdal Medical AS
  • Ambu A/S
  • 3B Scientific GmbH
  • Cardionics
  • DentalEZ, Inc.
  • Gaumard Scientific Co., Inc.
  • IngMar Medical
  • Kyoto Kagaku Co., Ltd.
  • Mentice AB
  • CAE Healthcare
  • Adam Rouilly Ltd.
  • Global Technologies
  • KOKEN CO., LTD.
  • LifeCast Body Simulation Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of COVID-19 and a Looming Global Recession
    • Year 2021 in Review and Near-term Outlook
    • Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook
    • World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2021, 2022 and 2023
    • COVID-19 Impact on Mannequin-Based Simulation
    • Mannequin - A Prelude
    • Simulation Based Education
    • Nursing Education Embraces Simulation-based Learning in a Major Way
    • Mannequin-based Simulation: An Integral Part of Medical Simulation Market
    • Global Mannequin-based Simulation Market Set to Witness Significant Growth
    • Growth Drivers
    • Increasing Focus on Patient Safety
    • Limited Access to Live Patients Drives Market for Simulation
    • Simulation in Healthcare Enables Cost Reduction
    • Technology Revolution Drives Demand for Simulation
    • Affordability & Rising Implementation to Boost Demand
    • Developed Regions: Primary Revenue Contributors
    • Developing Regions Offer High Growth Potential for Mannequin-based Simulation
    • Patient Simulators Lead the Mannequin-based Simulation Market
    • Competition
    • Mannequin-Based Simulation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increase in Surgeries Augurs Well for Market Growth
    • Global Surgical Procedure Volume by Procedure Type
    • Rise in Global Surgeries Post COVID & Shortage of Surgeons to Drive Use of Mannequin-based Simulation to Accelerate Surgeon Education and Training
    • Surgical Backlog & Surgeon Shortages: A Harrowing Situation
    • Cancer Surgery Demand Surges Amid Surgeon Shortage
    • Mannequin-based Simulation to the Rescue
    • As the Number of Surgeries Performed Globally Increase, the Need for Well Trained Surgeons Becomes Acute, Strengthening the Business Case for Mannequin-based Simulation: Global Market for General Surgery (In US$ Billion) for Years 2018, 2020, 2022, 2024, 2026 and 2028
    • Virtual Simulation and High-Fidelity Mannequin Simulation for Recognizing Critical Events
    • High-fidelity Mannequins
    • Advanced Mannequins Imitate Human Reactions
    • Increasing Healthcare Expenditure to Foster Growth
    • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
    • Mannequin-based Simulation for Nursing Schools
    • Cardiology, a Promising Field for Medical Animation/Simulation
    • Simulation Benefits Interventional Cardiology
    • Mannequins Gain Traction in Military Medical Training
    • Minimally-invasive Procedures Necessitate Simulation-based Training
    • Robot-assisted Surgical Simulation Training Gaining Significance
    • Simulation Training Preferred for Cataract Surgery
    • Surgical Simulation Gets Notable Makeover with Influx of Innovative Approaches
    • Surgical Simulation: The History & Evolution
    • Existing Surgical Simulation Models
    • Continuing Advances Pave Way for Versatile & Realistic Surgical Simulators
    • Innovations Set to Take Surgical Simulation to Next Level
    • Select Innovations
    • Learning Theories Guiding Development of Simulation-based Education
    • Areas where Under Graduate Nursing Education Simulation is Most Used
    • Virtual Simulations for UG Nursing Programs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mannequin-Based Simulation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 4: World 16-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 7: World 16-Year Perspective for Patient Simulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 10: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 13: World 16-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • TABLE 38: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: China 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: China 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • TABLE 53: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: France 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: France 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • TABLE 71: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION